×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
Faculty of Healt... [2]
THE STATE KEY LA... [2]
Authors
TAM KIN YIP [1]
HE CHENGWEI [1]
Document Type
Journal article [3]
Date Issued
2023 [1]
2021 [1]
2018 [1]
Language
英語English [3]
Source Publication
Bioorganic Chemi... [1]
EUROPEAN JOURNAL... [1]
JOURNAL OF CANCE... [1]
Indexed By
SCIE [3]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor
Journal article
Sun, Yaoliang, Chen, Zhiwen, Liu, Guobin, Chen, Xiaoai, Shi, Zihan, Feng, Huixu, Yu, Lei, Li, Guodong, Ding, Ke, Huang, He, Zhang, Zhang, Xu, Shilin. Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor[J]. Bioorganic Chemistry, 2023, 143, 107053.
Authors:
Sun, Yaoliang
;
Chen, Zhiwen
;
Liu, Guobin
;
Chen, Xiaoai
;
Shi, Zihan
; et al.
Favorite
|
TC[WOS]:
1
TC[Scopus]:
1
IF:
4.5
/
4.7
|
Submit date:2024/02/22
Cancer
Covalent
Inhibitor
Threonine Tyrosine Kinase (Ttk)
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy
Journal article
Yuxin Zhao, Haiyong Wang, Chengwei He. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147(12), 3653-3664.
Authors:
Yuxin Zhao
;
Haiyong Wang
;
Chengwei He
Favorite
|
TC[WOS]:
20
TC[Scopus]:
19
IF:
2.7
/
3.1
|
Submit date:2021/12/08
Non-small Cell Lung Cancer
Targeted Therapy
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor
Drug Resistance
Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer
Journal article
Yang, Zheng, Zhang, Shao-Lin, Hu, Xiaohui, Tam, Kin Yip. Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 838, 41-52.
Authors:
Yang, Zheng
;
Zhang, Shao-Lin
;
Hu, Xiaohui
;
Tam, Kin Yip
Favorite
|
TC[WOS]:
27
TC[Scopus]:
27
IF:
4.2
/
4.3
|
Submit date:2018/10/30
Dichloroacetophenone
Epidermal Growth Factor Receptor
Tyrosine Kinase Inhibitor
Synergism
Hypoxia
Oxidative Phosphorylation